
    
      Objective:

      To study the impact of wearable cardioverter defibrillator (WCD) use on sudden cardiac death
      in hemodialysis patients.

      Study Population:

      Participants will be patients beginning hemodialysis (<2 months from initiation) who are â‰¥ 50
      years old.

      Intervention:

      A WCD will be used for protection against sudden cardiac death (SCD).

      Study Design:

      The study will be a multi-center, prospective, randomized controlled trial with 1:1
      assignment of treatment and control.

      Study Size:

      The study will enroll up to 2,600 subjects. A maximum of 200 sites will be used for
      enrollment.
    
  